Payment overview · 2025
General Payments
$245.28
8 reported records · 1 companies
Healthcare provider profile · identity verified
Danielle Duret, MD
Allopathic & Osteopathic Physicians|Internal Medicine · BRONX, NY · NPI 1942393152
Verified facts
What the public records show
CMS Open Payments records show Danielle Duret, MD received $245.28 in general payments during 2025 across 8 reported records.
Novo Nordisk Inc accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic, Rybelsus.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 230 claims for Ozempic by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 12 claims for Rybelsus by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $245.28 | 100.0% | 8 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $245.28 | 8 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $171.11 | 5 | 2025 |
Source payment records
|
|||||
| Wegovy Normalized: wegovy |
Drug | Novo Nordisk Inc | $74.17 | 3 | 2025 |
Source payment records
|
|||||
| Rybelsus Normalized: rybelsus |
Drug | Novo Nordisk Inc | $66.65 | 4 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 230 | exact normalized | Medicare Part D |
| Rybelsus rybelsus |
2025 | Rybelsus | 2024 | 12 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
230 | 39 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Rybelsus open payments reported associated product |
CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076 |
Rybelsus · 2024 Exact normalized brand match · 1 Part D row |
12 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 965 | 284 |
| Omeprazole | Omeprazole | 877 | 218 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 854 | 206 |
| Fluticasone Propionate | Fluticasone Propionate | 816 | 197 |
| Gabapentin | Gabapentin | 793 | 161 |
| Ammonium Lactate | Ammonium Lactate | 732 | 139 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 728 | 209 |
| Diclofenac Sodium | Diclofenac Sodium | 725 | 174 |
| Amlodipine Besylate | Amlodipine Besylate | 610 | 174 |
| Azelastine Hcl | Azelastine Hcl | 483 | 100 |
| Metformin Hcl | Metformin Hcl | 469 | 135 |
| Alendronate Sodium | Alendronate Sodium | 439 | 132 |
| Lisinopril | Lisinopril | 427 | 128 |
| Ibuprofen | Ibuprofen | 423 | 120 |
| Losartan Potassium | Losartan Potassium | 401 | 125 |
| Famotidine | Famotidine | 393 | 111 |
| Meclizine Hcl | Meclizine Hcl | 382 | 96 |
| Montelukast Sodium | Montelukast Sodium | 377 | 109 |
| Ketoconazole | Ketoconazole | 349 | 81 |
| Hydrochlorothiazide | Hydrochlorothiazide | 341 | 94 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 338 | 108 |
| Naproxen | Naproxen | 315 | 83 |
| Metoprolol Succinate | Metoprolol Succinate | 297 | 87 |
| Zolpidem Tartrate | Zolpidem Tartrate | 262 | 47 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 240 | 72 |
| Ozempic | Semaglutide | 230 | 39 |
| Mirtazapine | Mirtazapine | 219 | 49 |
| Trazodone Hcl | Trazodone Hcl | 214 | 39 |
| Januvia | Sitagliptin Phosphate | 209 | 49 |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 207 | 60 |
| Meloxicam | Meloxicam | 189 | 56 |
| Tramadol Hcl | Tramadol Hcl | 186 | 44 |
| Memantine Hcl | Memantine Hcl | 170 | 47 |
| Simvastatin | Simvastatin | 164 | 54 |
| Jardiance | Empagliflozin | 161 | 44 |
| Ezetimibe | Ezetimibe | 159 | 44 |
| Nifedipine Er | Nifedipine | 159 | 50 |
| Tamsulosin Hcl | Tamsulosin Hcl | 158 | 43 |
| Restasis | Cyclosporine | 157 | 33 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 156 | 50 |
| Estradiol | Estradiol | 151 | 37 |
| Eliquis | Apixaban | 149 | 34 |
| Sertraline Hcl | Sertraline Hcl | 149 | 41 |
| Levothyroxine Sodium | Levothyroxine Sodium | 148 | 43 |
| Baclofen | Baclofen | 146 | 35 |
| Furosemide | Furosemide | 146 | 35 |
| Hydrocortisone | Hydrocortisone | 133 | 34 |
| Pantoprazole Sodium | Pantoprazole Sodium | 133 | 42 |
| Pregabalin | Pregabalin | 130 | 24 |
| Prednisone | Prednisone | 127 | 71 |
| Mometasone Furoate | Mometasone Furoate | 120 | 64 |
| Sumatriptan Succinate | Sumatriptan Succinate | 117 | 15 |
| Duloxetine Hcl | Duloxetine Hcl | 116 | 37 |
| Metoprolol Tartrate | Metoprolol Tartrate | 115 | 34 |
| Single Use Swab | Alcohol Antiseptic Pads | 114 | 39 |
| Carvedilol | Carvedilol | 110 | 30 |
| Latanoprost | Latanoprost | 110 | 27 |
| Glimepiride | Glimepiride | 109 | 25 |
| Atenolol | Atenolol | 104 | 27 |
| Escitalopram Oxalate | Escitalopram Oxalate | 104 | 33 |
| Celecoxib | Celecoxib | 103 | 31 |
| Clopidogrel | Clopidogrel Bisulfate | 100 | 33 |
| Folic Acid | Folic Acid | 95 | 17 |
| Fluocinonide | Fluocinonide | 94 | 27 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 94 | 29 |
| Vascepa | Icosapent Ethyl | 88 | 19 |
| Donepezil Hcl | Donepezil Hcl | 86 | 23 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 85 | 16 |
| Ibu | Ibuprofen | 85 | 28 |
| Easy Touch Alcohol Prep Pads | Alcohol Antiseptic Pads | 80 | 25 |
| Quetiapine Fumarate | Quetiapine Fumarate | 80 | 25 |
| Buspirone Hcl | Buspirone Hcl | 79 | 21 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 79 | 19 |
| Allopurinol | Allopurinol | 77 | 21 |
| Breo Ellipta | Fluticasone/Vilanterol | 76 | 17 |
| Azithromycin | Azithromycin | 72 | 55 |
| Valsartan | Valsartan | 72 | 21 |
| Lidocaine | Lidocaine | 68 | 17 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 62 | 18 |
| Trulicity | Dulaglutide | 62 | 15 |
| Xiidra | Lifitegrast | 62 | 16 |
| True Comfort Pro Alcohol Pads | Alcohol Antiseptic Pads | 60 | 22 |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 57 | 18 |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 57 | 14 |
| Metformin Hcl Er | Metformin Hcl | 56 | 18 |
| Prednisolone Acetate | Prednisolone Acetate | 54 | 14 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 52 | 11 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 52 | suppressed |
| Colchicine | Colchicine | 51 | 15 |
| Nystatin | Nystatin | 51 | 19 |
| Procto-Med Hc | Hydrocortisone | 51 | 14 |
| Valacyclovir | Valacyclovir Hcl | 51 | 18 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 48 | 40 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 48 | 15 |
| Alcohol Swabs | Alcohol Antiseptic Pads | 47 | 15 |
| Clotrimazole | Clotrimazole | 45 | 11 |
| Benazepril Hcl | Benazepril Hcl | 44 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 44 | 11 |
| Bupropion Xl | Bupropion Hcl | 43 | suppressed |
| Mupirocin | Mupirocin | 43 | 18 |
| Amitriptyline Hcl | Amitriptyline Hcl | 42 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 42 | 14 |
| Linzess | Linaclotide | 42 | 11 |
| Enalapril Maleate | Enalapril Maleate | 41 | 11 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 41 | 16 |
| Potassium Chloride | Potassium Chloride | 40 | 12 |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 40 | 11 |
| Entresto | Sacubitril/Valsartan | 39 | suppressed |
| Trospium Chloride | Trospium Chloride | 39 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 38 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 37 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 36 | 17 |
| Chlorthalidone | Chlorthalidone | 36 | 13 |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 36 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 36 | suppressed |
| Ciclopirox | Ciclopirox Olamine | 35 | 13 |
| Torsemide | Torsemide | 35 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 34 | 12 |
| Topiramate | Topiramate | 34 | suppressed |
| Fluticasone Propionate Hfa | Fluticasone Propionate | 33 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 33 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 33 | 11 |
| Epinephrine | Epinephrine | 32 | 17 |
| Farxiga | Dapagliflozin Propanediol | 32 | suppressed |
| Finasteride | Finasteride | 32 | suppressed |
| Levetiracetam | Levetiracetam | 32 | suppressed |
| Methotrexate | Methotrexate Sodium | 32 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 32 | suppressed |
| Myrbetriq | Mirabegron | 31 | suppressed |
| Spironolactone | Spironolactone | 31 | suppressed |
| Glipizide Er | Glipizide | 30 | 12 |
| Paroxetine Hcl | Paroxetine Hcl | 30 | suppressed |
| Novolog Flexpen | Insulin Aspart | 29 | 11 |
| Ventolin Hfa | Albuterol Sulfate | 29 | 11 |
| Xarelto | Rivaroxaban | 29 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 28 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 28 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 28 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 28 | 16 |
| Timolol Maleate | Timolol Maleate | 28 | suppressed |
| Tramadol Hcl-Acetaminophen | Tramadol Hcl/Acetaminophen | 28 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 27 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 27 | suppressed |
| Clonazepam | Clonazepam | 27 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 27 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 27 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 27 | suppressed |
| Betamethasone Diprop Augmented | Betamethasone/Propylene Glyc | 26 | suppressed |
| Diclofenac Potassium | Diclofenac Potassium | 26 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 26 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 25 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 25 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 24 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 24 | suppressed |
| Levemir Flexpen | Insulin Detemir | 24 | suppressed |
| Synthroid | Levothyroxine Sodium | 24 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 24 | suppressed |
| Alcohol Swab | Alcohol Antiseptic Pads | 23 | 14 |
| Nitroglycerin | Nitroglycerin | 23 | suppressed |
| Fluconazole | Fluconazole | 22 | 17 |
| Tizanidine Hcl | Tizanidine Hcl | 22 | suppressed |
| Betamethasone Valerate | Betamethasone Valerate | 21 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 21 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 21 | suppressed |
| Lovastatin | Lovastatin | 21 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 21 | suppressed |
| True Comfort Safety Pen Needle | Pen Needle, Diabetic, Safety | 21 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 20 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 20 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 20 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 20 | suppressed |
| Ciclopirox | Ciclopirox | 19 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 19 | suppressed |
| Lorazepam | Lorazepam | 19 | suppressed |
| Mounjaro | Tirzepatide | 19 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 19 | 15 |
| Tradjenta | Linagliptin | 19 | suppressed |
| Anastrozole | Anastrozole | 18 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 18 | suppressed |
| Lumigan | Bimatoprost | 18 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 18 | suppressed |
| Selenium Sulfide | Selenium Sulfide | 18 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 18 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 18 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 17 | 16 |
| Cholestyramine | Cholestyramine (With Sugar) | 17 | suppressed |
| Verapamil Er | Verapamil Hcl | 17 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 16 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Nystop | Nystatin | 16 | suppressed |
| Risperidone | Risperidone | 16 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 15 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 15 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 15 | suppressed |
| Lactulose | Lactulose | 15 | suppressed |
| Prolia | Denosumab | 15 | suppressed |
| Sucralfate | Sucralfate | 15 | suppressed |
| Tacrolimus | Tacrolimus | 15 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Carbamazepine | Carbamazepine | 14 | suppressed |
| Diclofenac Sodium Er | Diclofenac Sodium | 14 | suppressed |
| Methimazole | Methimazole | 14 | suppressed |
| Proctozone-Hc | Hydrocortisone | 14 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 14 | 12 |
| Bupropion Hcl Sr | Bupropion Hcl | 13 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 13 | suppressed |
| Fluocinolone Acetonide | Fluocinolone Acetonide | 13 | suppressed |
| Oxycontin | Oxycodone Hcl | 13 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 12 | suppressed |
| Biktarvy | Bictegrav/Emtricit/Tenofov Ala | 12 | suppressed |
| Cartia Xt | Diltiazem Hcl | 12 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 12 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 12 | suppressed |
| Isentress | Raltegravir Potassium | 12 | suppressed |
| Levemir Flextouch | Insulin Detemir | 12 | suppressed |
| Lidocaine-Prilocaine | Lidocaine/Prilocaine | 12 | suppressed |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 12 | suppressed |
| Prezcobix | Darunavir/Cobicistat | 12 | suppressed |
| Rybelsus | Semaglutide | 12 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 12 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 11 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 11 | suppressed |
| Flurbiprofen | Flurbiprofen | 11 | suppressed |
| Frovatriptan Succinate | Frovatriptan Succinate | 11 | suppressed |
| Lamotrigine | Lamotrigine | 11 | suppressed |
| Naproxen Sodium | Naproxen Sodium | 11 | suppressed |
| Novofine 32 | Pen Needle, Diabetic | 11 | suppressed |
| Novofine Plus | Pen Needle, Diabetic | 11 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 11 | suppressed |
| Terconazole | Terconazole | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $245.28 · 8 records | Novo Nordisk Inc | Ozempic, Rybelsus, Wegovy | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ozempic play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error